美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Defiance Leveraged Long + Income HIMS ETF

5.43

0.0000

成交量：- -

成交額：- -

市值：271.36萬

市盈率：- -

高：5.43

開：5.43

低：5.43

收：5.43

52周最高：28.09

52周最低：4.63

股本：50.00萬

流通股本：50.00萬

量比：- -

換手率：- -

股息：5.56

股息率：102.40%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

市場消息： HIMS 的減重方案因信用卡糾紛遭到處罰。

巴克萊預計Hims銷售額將實現增長，但短期內面臨盈利壓力

隨着Hims準備推出肽類產品，華爾街對其今年的前景持謹慎態度

美國股市-受美伊僵局推高油價影響，華爾街期貨走勢平淡

Riot Platforms盤前暴漲逾21%，與Anthropic達成91億美元算力協議；Rocket Lab USA、USA Rare Earth績後跌超8%

老虎资讯综合

盤前異動 | 美股三大股指期貨齊跌；Riot簽下91億大單，盤前大漲22%；B&W二季度業績公布，盤前暴漲39%；Life360、Upwork重挫，跌逾19%

老虎资讯综合

美股夜盤｜Riot Platforms漲26%；新聞集團漲1%；RKLB跌7%；普拉格能源漲6%

Hims & Hers Q2營收增長38%，上調全年收入指引，但轉盈為虧拖累盤後股價

老虎资讯综合

Hims & Hers Health預計毛利率將持續低於歷史水平，因國際及減肥業務擴張——電話會議透露

Hims & Hers Health提前測試肽類成分，靜待FDA關於允許藥物配製的決定——電話會議透露

Hims & Hers Health：CFO稱國際業務與減肥產品拖累Q2利潤率

Hims & Hers Health CFO：若現行法規允許，有信心快速擴大肽類產品規模

「Hims and Hers」股價上漲，因上調業績預期且季度營收增長

Hims & Hers Health Inc.：預計AI投資將在12至18個月內實現自我回報，並有望讓產品對客户更實惠

Hims & Hers Health：預計其國內業務將在下半年持續加速增長

得益於訂閲用户數量的強勁增長，Hims & Hers 季度營收實現增長

Hims & Hers Health：對2030年至少65億美元營收及13億美元調整後EBITDA目標信心倍增

ETF日報 | 2倍沽空IREN ETF升逾27%；2倍沽空AAOI ETF漲近27%；三倍沽空半導體ETF升逾16%；科技沽空與原油走強

Hims & Hers回應FTC訴訟：指控忽視公司近三年調查期間提供的充分證據

Hims & Hers Health 回應FTC訴訟：我們立場堅定，將積極捍衞自身權益，堅決駁斥這些毫無根據的指控

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/HIMY/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HIMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMY\",,,,,undefined,":{"symbol":"HIMY","market":"US","secType":"STK","nameCN":"Defiance Leveraged Long + Income HIMS ETF","latestPrice":5.4272,"timestamp":1787342400000,"preClose":5.4272,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":500000,"shares":500000,"eps":0,"marketStatus":"未開盤","change":0,"latestTime":"08-21 16:00:00 EDT","open":5.4272,"high":5.4272,"low":5.4272,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":5.4272,"sharesOutstanding":450000,"nav":5.39,"aum":2430000,"dividendRate":1.024009,"bidAskSpread":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMY\",,,,,undefined,":{"symbol":"HIMY","floatShares":500000,"roa":"--","roe":"--","lyrEps":0,"shares":500000,"dividePrice":5.5575,"high":5.4272,"amplitude":0,"preClose":5.4272,"low":5.4272,"week52Low":4.6299,"pbRate":"--","week52High":28.0918,"institutionHeld":0,"latestPrice":5.4272,"eps":0,"divideRate":1.024009,"volume":0,"delay":0,"ttmEps":0,"open":5.4272,"prevYearClose":6.5028,"prevWeekClose":5.4272,"prevMonthClose":5.4272,"prevQuarterClose":5.4272,"fiveDayClose":5.4272,"twentyDayClose":5.4272,"sixtyDayClose":5.4272},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HIMY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-01-27","symbol":"HIMY","reason":null,"defaultRemindTime":1769524200000,"announcedDate":"2026-01-26","type":"delisting","dateTimestamp":1769490000000},{"date":"2026-01-21","symbol":"HIMY","amount":0.0727,"announcedDate":"2026-01-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-21","defaultRemindTime":1769005800000,"name":"Defiance Leveraged Long + Income HIMS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-22","payableDate":"2026-01-21","currency":"USD","dateTimestamp":1768971600000,"payDate":"2026-01-22"},{"date":"2026-01-14","symbol":"HIMY","amount":0.0725,"announcedDate":"2026-01-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-14","defaultRemindTime":1768401000000,"name":"Defiance Leveraged Long + Income HIMS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-15","payableDate":"2026-01-14","currency":"USD","dateTimestamp":1768366800000,"payDate":"2026-01-15"},{"date":"2026-01-07","symbol":"HIMY","amount":0.1045,"announcedDate":"2026-01-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-07","defaultRemindTime":1767796200000,"name":"Defiance Leveraged Long + Income HIMS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-08","payableDate":"2026-01-07","currency":"USD","dateTimestamp":1767762000000,"payDate":"2026-01-08"},{"date":"2025-12-31","symbol":"HIMY","amount":0.1087,"announcedDate":"2025-12-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-31","defaultRemindTime":1767191400000,"name":"Defiance Leveraged Long + Income HIMS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-02","payableDate":"2025-12-31","currency":"USD","dateTimestamp":1767157200000,"payDate":"2026-01-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HIMY\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-03","recordDate":"2025-09-03","paymentDate":"2025-09-04","value":0.2607,"currency":"USD"},{"executeDate":"2025-09-10","recordDate":"2025-09-10","paymentDate":"2025-09-11","value":0.3316,"currency":"USD"},{"executeDate":"2025-09-17","recordDate":"2025-09-17","paymentDate":"2025-09-18","value":0.3517,"currency":"USD"},{"executeDate":"2025-09-24","recordDate":"2025-09-24","paymentDate":"2025-09-25","value":0.5051,"currency":"USD"},{"executeDate":"2025-10-01","recordDate":"2025-10-01","paymentDate":"2025-10-02","value":0.5127,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HIMY\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HIMY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661290875","title":"市場消息： HIMS 的減重方案因信用卡糾紛遭到處罰。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290875","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661290875?lang=zh_tw&edition=fundamental","pubTime":"2026-08-22 04:49","pubTimestamp":1787345385,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4196","HEAL","HIMY","HMYY","HIMS","HIMZ","HIMC","THNR","GLAM","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287705","title":"巴克萊預計Hims銷售額將實現增長，但短期內面臨盈利壓力","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287705","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287705?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 21:43","pubTimestamp":1787233415,"startTime":"0","endTime":"0","summary":"BUZZ-巴克莱预计Hims销售额将实现增长，但短期内面临盈利压力8月20日-** 远程医疗公司 Hims & Hers Health（HIMS.N）的股价在早盘交易中上涨 4%，至 32.35 美元** 巴克莱表示，预计HIMS的营收将实现增长，这主要得益于收购以及新业务领域的强劲增长** 但该行认为，“为支持增长而进行的投资将带来一定利润率压力”，这可能对近期盈利能力构成拖累** 该券商将该股","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4T44H12W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","GLAM","HEAL","HIYY","HIMS","HIMZ","THNR","HIMY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659902383","title":"隨着Hims準備推出肽類產品，華爾街對其今年的前景持謹慎態度","url":"https://stock-news.laohu8.com/highlight/detail?id=2659902383","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659902383?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 02:32","pubTimestamp":1786559535,"startTime":"0","endTime":"0","summary":"随着Hims准备推出肽类产品，华尔街对其今年的前景持谨慎态度Hims计划在年底前销售可合法生产的肽类产品分析师称，灰色市场上的肽类销售使得NAD+的需求难以量化一家配制药企的首席执行官表示，执法部门的酌情权可能允许更早地进行中期上市Amina Niasse路透纽约8月12日-Hims & Hers Health 计划于 2026 年推出部分合法可用的肽类产品，但本周这家远程医疗公司公布季度财报后，接受路透采访的投资者和分析师表示，该产品线的销售不太可能推动今年的营收增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4S4491HY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","HMYY","THNR","HIMZ","BK4196","HIMS","GLAM","HIYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658686991","title":"美國股市-受美伊僵局推高油價影響，華爾街期貨走勢平淡","url":"https://stock-news.laohu8.com/highlight/detail?id=2658686991","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658686991?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 18:23","pubTimestamp":1786443814,"startTime":"0","endTime":"0","summary":"美国股市-受美伊僵局推高油价影响，华尔街期货走势平淡如需查看路透关于美国、英国和欧洲股市的实时博客，请点击LIVE/或在新闻窗口中输入LIVE/。期货：道指下跌0.09%，标普500指数上涨0.02%，纳斯达克指数上涨0.11%路透8月11日-周二，美国股指期货走势平淡，因美伊谈判陷入僵局推高了油价，令投资者在通胀前景仍不明朗的情况下不愿冒险。运动服饰品牌OnONON.N在美上市股价下跌16.2%，此前该公司第二季度净销售额未达  华尔街预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4T4480NA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DAPP","VGT","AIPI","GLAM","RKLX","QQQA","JGRO","RIOX","NVDS.UK","SOXX","HIMZ","NVD2.UK","THMR","THNR","HMYY","SMHX","BKCH","RIOT","AIQ","SOXQ","FDTX","INTW","METV","ARTY","HIMY","NVD3.UK","AGOX","HEAL","RKLB","ABFL","XLK","SMH","CMAG","TRFK","CLSE","CNEQ","SNVD.UK","XNTK","BLOX","AIFD","WISE","DRIV","RKLZ","FAI","TEK","HIMS","INTC","HIYY","NVDA","TYLG"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1180557150","title":"Riot Platforms盤前暴漲逾21%，與Anthropic達成91億美元算力協議；Rocket Lab USA、USA Rare Earth績後跌超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1180557150","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180557150?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 16:07","pubTimestamp":1786435649,"startTime":"0","endTime":"0","summary":"云计算公司 $Riot Platforms(RIOT)$盘前暴涨逾21%，与Anthropic达成91亿美元算力协议； $Rocket Lab USA, Inc.(RKLB)$、 $USA Rare Earth Inc.(USAR)$跌超8%， $Hims & Hers Health Inc.(HIMS)$ 跌超7%，此前均公布最新业绩。","market":"us","thumbnail":"https://static.tigerbbs.com/8563c55eda230bf12ce63dc5314b95d0","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8563c55eda230bf12ce63dc5314b95d0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","RIOT","RKLX","HMYY","RIOX","USAR","USAX","HIMY","HIMS","RTYY","RKLZ","HIYY","USGG","RKLB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164330137","title":"盤前異動 | 美股三大股指期貨齊跌；Riot簽下91億大單，盤前大漲22%；B&W二季度業績公布，盤前暴漲39%；Life360、Upwork重挫，跌逾19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1164330137","media":"老虎资讯综合","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164330137?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 16:04","pubTimestamp":1786435492,"startTime":"0","endTime":"0","summary":"美国股指期货周二齐跌。与道琼斯工业平均指数挂钩的期货跌 0.23%；标普500指数期货微跌 0.01%；纳斯达克100指数期货跌 0.23%。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","HMYY","USAR","RDWU","RDW","RKLZ","UPWK","USGG","HIMS","RKLB","LIF","USAX","HIMZ","BW","RKLX","HIMY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1118884582","title":"美股夜盤｜Riot Platforms漲26%；新聞集團漲1%；RKLB跌7%；普拉格能源漲6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1118884582","media":"美股夜盘","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118884582?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 08:06","pubTimestamp":1786406783,"startTime":"0","endTime":"0","summary":"Riot Platforms涨25.77%，宣布与前沿AI实验室签署为期20年的191兆瓦数据中心租赁，预计总收入91亿美元，推进向AI/HPC转型。SpaceX跌1.59%，SEC就涉及SpaceX的IPO前股票欺诈指控与Adit达成和解，私募二级交易规范化受关注，相关舆情扰动情绪。Hims & Hers Health Inc. 跌6.83%，Q2每股亏损0.37美元远超预期，由盈转亏，管理层称国际拓展与品牌减重药拖累毛利率并产生重组成本。Rocket Lab USA, Inc. 跌7.02%，Q2营收超预期但每股亏损逊预期，且Q3 GAAP毛利率指引29%-31%低于市场预期，Neutron首飞时间或再推迟。","market":"us","thumbnail":"https://static.tigerbbs.com/02ad453d1404f80bdd57419bc97bfad5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/02ad453d1404f80bdd57419bc97bfad5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FSPC","LOFD","RKLB","HYDR","LU1548497426.USD","SNK","SPCU","LU1720051017.SGD","RIOT","ELOL","RTYY","HIMZ","BK4564","LOFF","BLOX","RKLZ","BK4111","SSPC","CTEX","SPAX","USGG","IBLC","BK4600","USAX","BK4588","PLUL","BK4023","HMYY","BK4595","SPCQ","LU0823414478.USD","LU2249611893.SGD","LU1169589451.USD","SPCF","LU1720051108.HKD","SPCM","RIOX","SPCX","HIYY","DAPP","LU2357305700.SGD","USAR","BK4585","LU1169590202.USD","BK4615","PLUG","BK4096","BK4187","BK4516","BKCH","LFGY","NWSA","RKLX","HIMY","DIPR","BK4541","SPCH","SPAL","SPCG","HIMS"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1105273591","title":"Hims & Hers Q2營收增長38%，上調全年收入指引，但轉盈為虧拖累盤後股價","url":"https://stock-news.laohu8.com/highlight/detail?id=1105273591","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105273591?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 07:24","pubTimestamp":1786404286,"startTime":"0","endTime":"0","summary":"财报显示，Hims & Hers第二季度实现营收7.53亿美元，同比增长38%；订阅用户总数增至约289万，同比增长19%；每位订阅用户月均收入达到92美元，同比增长21%，反映用户消费金额持续提升。Hims & Hers将2026年全年营收指引由原先的28亿至30亿美元，上调至31亿至33亿美元；第三季度预计营收为8.8亿至9亿美元，同样高于市场预期。受此影响，Hims & Hers股价在盘后交易中下跌约7%，尽管营收超出市场预期且全年收入指引获得上调。","market":"us","thumbnail":"https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcR-qMPbNE-LY2BuQBFt6mZxC79w2Pptk9wS91cqArf44A&s=10","type":0,"news_type":0,"thumbnails":["https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcR-qMPbNE-LY2BuQBFt6mZxC79w2Pptk9wS91cqArf44A&s=10"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"72e3de9ba94345e5a6a76224eeec6cd3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Q2营收增长38%，上调全年收入指引，但转盈为亏拖累盘后股价","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","HIYY","HIMS","HIMY","HMYY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1103305801","title":"Hims & Hers Health預計毛利率將持續低於歷史水平，因國際及減肥業務擴張——電話會議透露","url":"https://stock-news.laohu8.com/highlight/detail?id=1103305801","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103305801?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 05:34","pubTimestamp":1786397692,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc.在电话会议中透露，由于国际市场的拓展以及减肥业务的扩张，公司预计毛利率将长期维持在历史低位以下。这一趋势打破了以往相对稳定的盈利水平，反映出公司在全球化和新产品线布局上的大胆投入。尽管此举可能短期内压缩利润空间，但高层认为，这是实现长期增长的关键一步。随着业务版图不断延伸，毛利率的波动性或将加剧，从而考验投资者的耐心与信心。然而，管理层强调，这些战略调整旨在捕捉更广阔的市场机遇，而非简单的财务妥协。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","HMYY","THNR","HIMZ","BK4196","HIMS","GLAM","HIYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124573842","title":"Hims & Hers Health提前測試肽類成分，靜待FDA關於允許藥物配製的決定——電話會議透露","url":"https://stock-news.laohu8.com/highlight/detail?id=1124573842","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124573842?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 05:20","pubTimestamp":1786396838,"startTime":"0","endTime":"0","summary":"在即将到来的FDA关键决策之前，Hims & Hers Health Inc.已悄然展开肽类成分的测试工作。这家健康科技公司正密切关注监管机构是否允许针对这些药物进行配制。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","HEAL","HMYY","HIMZ","HIYY","HIMY","THNR","HIMS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168471363","title":"Hims & Hers Health：CFO稱國際業務與減肥產品拖累Q2利潤率","url":"https://stock-news.laohu8.com/highlight/detail?id=1168471363","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168471363?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 04:56","pubTimestamp":1786395415,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 首席财务官坦言，国际业务拓展以及减肥产品的销售，在第二季度拉低了公司的整体利润率。这些领域的运营特征，与核心业务相比，呈现出不同的盈利表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HMYY","HIMZ","HIMS","GLAM","BK4196","HEAL","THNR","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192063839","title":"Hims & Hers Health CFO：若現行法規允許，有信心快速擴大肽類產品規模","url":"https://stock-news.laohu8.com/highlight/detail?id=1192063839","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192063839?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 04:44","pubTimestamp":1786394681,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 首席财务官表示，公司对在现行法规允许的情况下快速扩大其肽类产品供应规模充满信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","HIMY","HIYY","HMYY","BK4196","HIMS","HEAL","GLAM","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658590369","title":"「Hims and Hers」股價上漲，因上調業績預期且季度營收增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2658590369","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658590369?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 04:21","pubTimestamp":1786393262,"startTime":"0","endTime":"0","summary":"BUZZ-“Hims and Hers”股价上涨，因上调业绩预期且季度营收增长8月10日-** 远程医疗公司 Hims & Hers（HIMS.N）的股价在盘后交易中上涨 3%，报 33 美元**得益于订阅用户数量增长及个性化医疗服务范围的扩大，HIMS公布第二季度营收增长(link)，并上调全年业绩预期** 据伦敦证券交易所集团（LSEG）汇编的数据，该公司第二季度营收为7.53亿美元，而去年同期为5.44亿美元；分析师此前预计营收为6.9989亿美元**将2026财年营收预期从之前的28亿至30亿美元区间上调至31亿至33亿美元** 计入当日交易波动，该股年初至今累计下跌2.2%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4T4471FP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMZ","HEAL","HIMY","THNR","HIMS","HMYY","HIYY","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137770526","title":"Hims & Hers Health Inc.：預計AI投資將在12至18個月內實現自我回報，並有望讓產品對客户更實惠","url":"https://stock-news.laohu8.com/highlight/detail?id=1137770526","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137770526?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 04:11","pubTimestamp":1786392685,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 预计其在人工智能领域的投资，将在12至18个月内实现自我回报。公司还预期，这些投入将有助于使其产品和服务对客户而言更加亲民、更具性价比。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","HEAL","HMYY","HIMZ","HIYY","HIMY","THNR","HIMS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169345584","title":"Hims & Hers Health：預計其國內業務將在下半年持續加速增長","url":"https://stock-news.laohu8.com/highlight/detail?id=1169345584","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169345584?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 04:09","pubTimestamp":1786392543,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 表示，预计其国内业务将在今年下半年继续加速扩张。这一乐观展望，凸显了公司对自身增长轨迹的坚定信心。随着市场对其健康解决方案的需求持续攀升，该企业正积极准备迎接新一轮业绩高峰。从当前态势看，其国内业务不仅有望维持强劲势头，更可能进一步突破预期，为整体财务表现注入源源不断的动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","HIMY","HMYY","BK4196","HEAL","GLAM","HIMS","THNR","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959351","title":"得益於訂閲用户數量的強勁增長，Hims & Hers 季度營收實現增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959351","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959351?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 04:08","pubTimestamp":1786392507,"startTime":"0","endTime":"0","summary":"得益于订阅用户数量的强劲增长，Hims & Hers 季度营收实现增长路透纽约8月10日-远程医疗公司Hims & Hers Health（HIMS.N）周一公布了第二季度营收增长，这得益于订阅用户数量的增加以及个性化医疗服务范围的扩大。该公司报告称，本季度营收为7.53亿美元，而去年同期为5.44亿美元。据伦敦证券交易所集团（LSEG）汇编的数据，分析师此前预计营收为6.9989亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4S4471EX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","HIMS","HIMY","THNR","HIMZ","HMYY","HEAL","HIYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131347768","title":"Hims & Hers Health：對2030年至少65億美元營收及13億美元調整後EBITDA目標信心倍增","url":"https://stock-news.laohu8.com/highlight/detail?id=1131347768","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131347768?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 04:07","pubTimestamp":1786392455,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc.正日益坚定地看好其2030年发展蓝图。该公司如今对实现至少65亿美元营收与13亿美元调整后EBITDA的远期目标，抱有愈发强烈的信心。这一雄心勃勃的规划，彰显了管理层对长期增长轨迹的笃定，以及公司战略执行力的持续强化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","HIMY","HIYY","HMYY","BK4196","HEAL","HIMZ","HIMS","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153012517","title":"ETF日報 | 2倍沽空IREN ETF升逾27%；2倍沽空AAOI ETF漲近27%；三倍沽空半導體ETF升逾16%；科技沽空與原油走強","url":"https://stock-news.laohu8.com/highlight/detail?id=1153012517","media":"ETF追踪","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153012517?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 08:20","pubTimestamp":1785370800,"startTime":"0","endTime":"0","summary":"美股ETF涨幅Top5Tradr 2X Short IREN Daily ETF上涨27.05%。Tradr 2X Short AAOI Daily ETF上涨26.61%。该产品两倍做空光子学芯片公司Applied Optoelectronics，底层公司股价走弱，杠杆机制放大当日涨幅。Tradr 2X ShortCBRS Daily ETF上涨22.27%。美股ETF跌幅Top5DEFIANCE DAILY TARGET 2X LONG LMND ETF下跌48.02%。2倍做多VRT ETF-GraniteShares下跌33.92%。纳指三倍做空ETF上涨6.30%。大宗商品ETF涨幅Top 5二倍做多彭博原油ETF上涨10.79%。二倍做空黄金矿业指数ETF-Direxion上涨2.09%。行业指数ETF涨幅Top 5三倍做空半导体ETF-Direxion Daily上涨16.35%。债券ETF涨幅Top 5FlexShares iBoxx 3 Year Target Duration TIPS Index Fund上涨0.25%。Vanguard Short-Term In","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","DWT","USL","NVTC","COWZ","TQQQ","LIAM","DMAX","OIH","QID","LU0329931173.USD","IBIL","OILK","WGMI","BK4551","LIAP","DOG","MVV","NVOX","USO","DZZ","BK7062","LU0823431647.USD","WTIU","NBIL","GTIP","DGP","SDOW","VTP","IBIJ","TIPZ","FDN","CBRS","USG","IBLC","LIBD","IBIC","DFIP","WTID","SPYH","LIAK","IEO","BK4107","GUSH","SPDN","NBIS","VTIP","APLX","OILU","PBTP","IWM","DBC","DRIP","XES","BK4020","IRE","LIAQ","TQQY","NJAN","IE0031619046.USD","SHNY","FBZ","SKF.AU","AAOZ","SCHP","IE00B66KJ199.SGD","512480","LITC","IE00B7SZL793.SGD","TZA","WIA","IE00B19Z4B17.USD","OSSL","LIAJ","NVOH","TDTT","QMmain","DDG","SPXS","MCLmain","YSPY","PSQ","BNDW","URTY","BK4535","SMDD","BK7095","NJUL","SPXL","VRTL","SIMX","TIPA","NBIC","BK4549","DXD","IBIE","PXJ","KGLD","HIYY","BK4023","LMND","STOT","USE","NBIZ","UWM","SRTY","LU0329931090.USD","BZmain","FLBR","IAU","BK7016","FCLD","MMAX","AAOI","LU0950373646.USD","PXE","DBE","GPIQ","ERX.AU","ETNG","ONTX","STCE","SKF","DUG","NEBX","KEEX","IGLD","CLmain","BK4097","SCO","SAA","QQQ","XITK","BK4585","BK4588","USOI","TWM","IBIK","DBO","NOCT","OILT","RBIL","IBIG","IREN","NUGT","BK4600","TIP.AU","QMAR","LMNX","SGOL","MNRS","TIPB","TIPD","DGZ","FTXN","IVV","LU0823431563.USD","APLZ","TNA","SH","BITQ","LIAW","DRLL","QQQX","LIAT","RGTC","BK4608","BK4570","IREZ","FAAR","SQQQ","BK4516","TEUP","SPYQ","VTWO","FGDL","APLD","AAAU","YGLD","BK4609","BNO","IREG","NRGZ","IXC","STPZ","DIA","FDIG","BAR","NAPR","HIBL","LIAX","LIAO","VOO","QDEC","IAUI","GLD","HMYY","ALA","IBII","IBIF","SSO","BKCH","STIP","GLL","SPUU","BGLD","DAPP","OUNZ","DULL","UGL","UDOW","LAZR","BK4141","IBIM","HIMZ","HIMY","IREX","XOP","SPIP","LIAU","DDM","TIP","SPXU","VRC","AAOX","SPYU","VRC.AU","YMmain","COZX","ERX","BK4593","FAZ","FNGD","IAUM","SDS","SPYM","QLD","LU0531971165.HKD","UPRO","SOXS","DUST","IBIH","BK4116","IBIB","BK4548","IBID","SPY","VDE","GLDM","SPXT","OILD","NBIG","XW","RIZE","CBRZ","DIG","HIBS","UGA","BK4077","QQQM","RWM","UCO","BK4595","SMAX","SGDJ","BK4007","GLDY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1132827512","title":"Hims & Hers回應FTC訴訟：指控忽視公司近三年調查期間提供的充分證據","url":"https://stock-news.laohu8.com/highlight/detail?id=1132827512","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132827512?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 01:22","pubTimestamp":1785345728,"startTime":"0","endTime":"0","summary":"针对美国联邦贸易委员会（FTC）的诉讼，Hims & Hers Health Inc. 公司发表声明。公司认为，这起诉讼完全无视了其在近三年调查过程中向FTC提交的大量实质性证据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","HIMY","THNR","BK4196","HMYY","HIMZ","HEAL","GLAM","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101602756","title":"Hims & Hers Health 回應FTC訴訟：我們立場堅定，將積極捍衞自身權益，堅決駁斥這些毫無根據的指控","url":"https://stock-news.laohu8.com/highlight/detail?id=1101602756","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101602756?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 01:21","pubTimestamp":1785345694,"startTime":"0","endTime":"0","summary":"面对美国联邦贸易委员会（FTC）提起的诉讼，Hims & Hers Health Inc.（HIMS）正式发声。该公司明确表态，坚信自身立场完全站得住脚，并誓言将采取强有力的法律行动，以抵御这些被其定性为“毫无根据”的指控。在官方回应中，Hims & Hers Health强调，他们不会屈服于压力，反而会以更加积极且坚决的姿态，为自己进行辩护。这一声明，既是对当前法律挑战的直接回应，也彰显了其捍卫公司声誉与商业模式的决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","THNR","HEAL","HMYY","GLAM","HIMS","HIYY","BK4196","HIMY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":132,"code":"91000000","status":"200"}]}}